Zyprexa News Archive
Judge urges Lilly to settle with plaintiffs over Zyprexa
-IndyStar
07/03/2008- Eli Lilly and Co., which already has paid more than $1 billion to settle legal claims over the side effects of its top-selling drug, Zyprexa, now faces another protracted legal battle over whether it improperly marketed and overcharged for the antipsychotic and should pay billions more to insurers. More>>>
Lilly Loses Appeal to Limit Damages in Canadian Suit
-Bloomberg
07/03/2008- Eli Lilly & Co. lost an appeal to limit potential damages in a lawsuit filed by Canadian patients who claimed they developed diabetes after using its Zyprexa schizophrenia drug. More>>>
FDA Expands Mortality Warnings on Antipsychotic Drugs
-FDA News
06/18/2008- The FDA has requested that boxed warnings about an increased risk of death in older people with dementia be added to a class of “conventional” antipsychotic drugs. More>>>
ADA: Metabolic Monitoring Guidelines for Antipsychotics Largely Unheeded
-Medpage Today
06/11/2008- Recommendations for lipid and glucose monitoring for patients on atypical antipsychotic drugs have made scarcely a dent on clinical practice, researchers found. More>>>
Unwanted consequences of antipsychotic drugs
-The Philadelphia Inquirer
05/31/2008- Antipsychotic drugs are often prescribed to treat agitation and other symptoms of dementia, but a new study suggests they may have unwanted consequences. More>>>
Antipsychotic Drugs Triple Risk of Death for Dementia Patients
-Bloomberg.com
05/27/2008- People with dementia more than tripled their risk of death or hospitalization within a month of taking antipsychotic drugs to silence their agitation, according to a study. More>>>
Eli Lilly STALLING on ZYPREXA Payout
-World Forum
05/02/2008 - Lilly's credibility over their continuous PR on how they are going to pay out $1.2 billion in Zyprexa damages Many claimants are being stonewalled. More>>>
Anti-Psychotic Drugs (Zyprexa) Change Metabolism
-American Psysiological Society
04/20/2008 - “Based on these findings we concluded that male rats treated with olanzapine experienced an early disruption of energy metabolism. More>>>
New Antipsychotics No Better For First Episodes
-Pharmalot
03/28/2008 - The so-called atypicals - including Abilify, Risperdal, Zyprexa, Seroquel and Geodon - have been hailed as more effective and easier to tolerate than the older and cheaper kind such as Haldol, which cause tremors and rigid muscles. But the new generation are no better at treating a first episode of schizophrenia, according to a study in The Lancet. More>>>
Eli Lilly Settling Zyprexa Lawsuit
-FDA News
03/28/2008 - Eli Lilly has agreed to pay Alaska $15 million to settle a lawsuit alleging the company made deceptive claims about Zyprexa, concealed the drug’s side effects and marketed it off-label for Medicaid recipients. More>>>
Alaska Suit Against Lilly Is Settled
-NY Times
03/27/2008 - The prospect of a pending Supreme Court case that could sweep away many lawsuits against drug companies loomed over Alaska’s decision to settle the state’s suit against Eli Lilly over the schizophrenia drug Zyprexa, lawyers for Lilly and the state said Wednesday. More>>>
Concerns About Supreme Court Case on Product Liability in State Courts Prompt Alaska To Settle Medicaid Lawsuit
-Kaiser Network
03/27/2008 - The $15 million settlement this week of a lawsuit filed by the state of Alaska against Eli Lilly over allegations that the company concealed data about the side effects of the antipsychotic Zyprexa More>>>
Lilly Settles Alaska Suit Over Zyprexa
-NY Times
03/26/2008 - Eli Lilly has agreed to pay $15 million to the state of Alaska to settle a lawsuit claiming that the company’s schizophrenia drug Zyprexa caused patients to develop diabetes, Lilly and the state said Wednesday morning. More>>>
Lilly settles Zyprexa case with Alaska for $15 mln
-Reuters
03/26/2008 - Eli Lilly and Co on Wednesday said it agreed to pay $15 million to settle a lawsuit by the state of Alaska accusing it of concealing possible side effects from Zyprexa, its widely used schizophrenia medicine. More>>>
Lilly agrees to $15 million payout to settle Alaskan Zyprexa case
-PharmaTimes
03/26/2008 - US drug giant Eli Lilly has agreed to pay the state of Alaska $15 million to settle claims that its Medicaid program was not adequately warned over potential side effects from the use of its antipsychotic Zyprexa. More>>>
Why Drug Lawsuits are Necessary: FDA “isn’t capable of policing” drug safety, says Alaska Judge
-Tort Deform
03/25/2008 - The state of Alaska is suing Eli Lilly (NYSE:LLY) for failing to disclose health risks (like diabetes and weight gain) allegedly associated with Lilly’s hugely profitable “atypical antipsychotic” drug Zyprexa. More>>>
Zyprexa: Balancing Serious Side Effects With Serious Illness
-Wall Street Journal
03/25/2008 - Lawyers for the state of Alaska have spent weeks arguing in an Anchorage courthouse that Eli Lilly hid the dangers of its antipsychotic drug Zyprexa — a claim Lilly denies. More>>>
Former Biotech CEO Indicted on Fraud Charges
-Wall Street Journal
03/19/2008 - The feds have indicted a former biotech CEO, arguing that he committed criminal acts when he promoted a drug for uses that hadn’t been approved by the FDA. More>>>
Lilly Zyprexa-Claim Losses May Climb to $1.83 a Share
-Bloomberg
03/18/2008 - An adverse jury decision in Alaska may be the first step in tripling to more than $3 billion Eli Lilly & Co.'s costs of resolving lawsuits over Zyprexa, which generates more than one-fourth of the company's revenue. More>>>
API patients on Zyprexa got diabetes, official says
-Anchorage Daily News
03/13/2008 - Patients taking the anti-psychotic drug Zyprexa needlessly developed diabetes because doctors didn't have all the information about risks, the medical director of Alaska's only public mental hospital said in court Wednesday. More>>>
Eli Lilly Denies Corrupt Practices On Zyprexa
-CNN
03/12/2008 - Eli Lilly & Co. (LLY) said it "strongly disagrees" with statements made by Connecticut Attorney General Richard Blumenthal Tuesday regarding the company's marketing of antipsychotic drug Zyprexa. More>>>
Lilly accused of "sick marketing mindset" in new Zyprexa lawsuit
-PharmaTimes
03/12/2008 - Connecticut has become the latest US state to sue Eli Lilly after claiming that the firm marketed the antipsychotic Zyprexa for unapproved off-label uses,and hid side effects such as weight gain and diabetes. More>>>
Connecticut Sues Eli Lilly Over Zyprexa
-eCanadaNow
03/12/2008 - Washington (eCanadaNow) - Connecticut has joined the list of states who have filed lawsuits against drug manufacturer Eli Lilly, over their Zyprexa drug. More>>>
Connecticut Sues Eli Lilly Over Zyprexa
-Wall Street Journal
03/11/2008 - Connecticut’s Attorney General Richard Blumenthal is suing Eli Lilly over the marketing of its antipsychotic drug Zyprexa, the AP reports. He ought to take a number — at least nine other states are suing the company for similar reasons. And federal prosecutors are also on the case, reportedly negotiating a big settlement with the company. More>>>
Antipsychotic meds may raise blood sugar
-Blog.wsj.com
03/02/2008 - Even as Eli Lilly’s lawyers are getting ready to defend a Zyprexa case in Alaska, the company’s got bad news from the FDA, four time zones away. The agency refused to approve the company’s application for a long-acting form of the anti-psychotic drug the company said this morning. More>>>>
Drug Company 'Eli Lilly' In Advanced Settlement Talks with Federal Investigators
-Tech News
02/27/2008 - Schizophrenia is a mental illness that affects over 2 million people in the U.S. Symptoms include severely impaired thinking, emotions, and behaviors. Typically, its onset is between the ages of 16 and 25 and about $70 billion is spent each year to treat the disease. More>>>>
Eli Lilly in Shareholder Cross Hairs
-FDA News
02/11/2008 - While Eli Lilly's Zyprexa troubles with the federal government may be coming to an end, the company faces new legal problems with a recent lawsuit filed by two of the company's shareholders. More>>>>
Long-Acting Zyprexa Works, But Has Sedation Risk, FDA Says
-Wall Street Journal
02/04/2008 -The Food and Drug Administration said Monday that a long-acting, injectable form of Eli Lilly & Co.'s top-selling drug Zyprexa was effective at treating schizophrenia but caused "profound sedation" in certain patients. More>>>>
Lilly Is in Talks to Settle Zyprexa Allegations
-Wall Street Journal
01/31/2008 - Eli Lilly & Co. is in advanced settlement talks with federal investigators regarding the company's marketing of antipsychotic drug Zyprexa, after a grand jury subpoena late last year raised the prospect that the company could be indicted. More>>>>
Lilly reportedly in talks with feds Newspaper: $1B payment
-Indianapolis Star
01/31/2008 - Eli Lilly and Co. could pay more than $1 billion to settle a criminal and civil investigation into the marketing of its antipsychotic drug Zyprexa, according to The New York Times, citing anonymous sources involved in the probe. More>>>>
Lilly subpoenaed on Zyprexa marketing
-LA Times
01/31/2008 - Eli Lilly & Co. said Wednesday that it received a subpoena in November from a U.S. grand jury in Pennsylvania seeking documents involving the marketing of the company's best selling drug, the antipsychotic Zyprexa. More>>>>
If you are currently taking Zyprexa and have concerns about its safety, you should consult with your doctor regarding your treatment options. Under no circumstances should you discontinue taking any medication, including Zyprexa, without first consulting with your doctor. For Zyprexa legal information contact the Zyprexa Attorneys of Ennis & Ennis, P.A. by filling out our free Zyrpexa case evaluation form or by calling the toll-free number listed below.
